批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/10/24 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/11/16 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/11/01 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/10/01 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/06/21 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/01/05 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/03/05 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2008/07/09 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/11/02 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/12/20 |
SUPPL-16(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2006/09/21 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/03/10 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/06/18 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/02/07 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/07/18 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:BALSALAZIDE DISODIUM 剂型/给药途径:CAPSULE;ORAL 规格:750MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020610 |
001 |
NDA |
COLAZAL |
BALSALAZIDE DISODIUM |
CAPSULE;ORAL |
750MG |
Prescription |
Yes |
Yes |
AB |
2000/07/18
|
VALEANT PHARMS INTL |
077806 |
001 |
ANDA |
BALSALAZIDE DISODIUM |
BALSALAZIDE DISODIUM |
CAPSULE;ORAL |
750MG |
Prescription |
No |
No |
AB |
2007/12/28
|
HIKMA |
077883 |
001 |
ANDA |
BALSALAZIDE DISODIUM |
BALSALAZIDE DISODIUM |
CAPSULE;ORAL |
750MG |
Prescription |
No |
No |
AB |
2007/12/28
|
APOTEX INC |
217592 |
001 |
ANDA |
BALSALAZIDE DISODIUM |
BALSALAZIDE DISODIUM |
CAPSULE;ORAL |
750MG |
Prescription |
No |
No |
AB |
2023/06/08
|
ZYDUS LIFESCIENCES |